NBP — NovaBridge Biosciences

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1778016 ·
Last close
$0.82
Market Cap
$95.10M
52W High
$5.19
52W Low
$0.75
ADV30
518,763
Next earnings
2026-08-20

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 231,542,000 190,637,000 30,438,000
Dec 2025 0 — -72,900,000 -30,787,000 260,522,000 210,632,000 29,581,000
Sep 2025 0 — -8,989,000 -6,828,000 277,410,000 228,064,000 18,495,000
Jun 2025 0 — -7,114,000 -5,504,000 206,708,000 165,404,000 9,975,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-12,757,000
Investing CF
$0
Financing CF
$57,725,000
CapEx
—
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.12
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,370,176,000
Inventory
—
Receivables
$5,640,000
ST Investments
$210,000
EBIT TTM
$-94,269,000
Pretax Income TTM
$-88,340,000
Interest Exp TTM
—
Analysts
3

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -94,269,000 -46,269,000 260,522,000 29,581,000 230,941,000 -20,597,000
Dec 2024 0 -51,426,000 -22,230,000 212,680,000 11,520,000 201,160,000 -52,669,000
Dec 2023 632,000 -48,976,000 -207,729,000 368,922,000 126,338,000 242,584,000 -72,697,000
Dec 2022 -1,551,000 -53,078,000 -371,053,000 590,446,132 168,678,417 421,767,716 -49,582,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.06

Peers — same industry

TickerNameMarket CapLastDaily %
RTSN Retension Pharmaceuticals, Inc. $95.06M $11.41 —
ANIX Anixa Biosciences Inc $92.82M $2.67 —
PMVP PMV Pharmaceuticals, Inc. $92.15M $1.22 —
HSTC HST Global, Inc. $99.00M $0.70 —
ADAG Adagene Inc. $99.37M $1.48 —

News headlines (Yahoo Finance, 1h cache)

Visara Announces First Patient Dosed in ASCEND Phase 2b Trial of VIS-101 in Wet AMD
2026-11-18 12:00 · Yahoo
NovaBridge Biosciences to Participate in Upcoming Investor Conferences
2026-11-09 12:00 · Yahoo
I-Mab Picks Givastomig Dose After Promising Gastric Cancer Data, Aligns With FDA
2026-11-03 05:12 · Yahoo
NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer
2026-10-28 11:00 · Yahoo
NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
2026-10-25 11:00 · Yahoo
Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia
2026-10-20 11:00 · Yahoo
Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis
2026-10-13 11:00 · Yahoo
NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026
2026-10-08 20:05 · Yahoo
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
2026-09-08 11:00 · Yahoo
NovaBridge Biosciences to Participate in September Investor Conferences
2026-08-27 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.